ABSOLUTE BIOMEDICAL LTD - ABERCYNON
Company Profile | Company Filings |
Overview
ABSOLUTE BIOMEDICAL LTD is a Private Limited Company from ABERCYNON WALES and has the status: Active.
ABSOLUTE BIOMEDICAL LTD was incorporated 3 years ago on 13/01/2021 and has the registered number: 13131330. The accounts status is MICRO ENTITY and accounts are next due on 31/10/2024.
ABSOLUTE BIOMEDICAL LTD was incorporated 3 years ago on 13/01/2021 and has the registered number: 13131330. The accounts status is MICRO ENTITY and accounts are next due on 31/10/2024.
ABSOLUTE BIOMEDICAL LTD - ABERCYNON
This company is listed in the following categories:
86220 - Specialists medical practice activities
86220 - Specialists medical practice activities
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 1 | 31/01/2023 | 31/10/2024 |
Registered Office
TY CYNON
ABERCYNON
RCT
CF45 4SN
WALES
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
12/01/2024 | 26/01/2025 |
Map
WALES
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MR ROBERT LEE HARRIS | Sep 1980 | British | Director | 2021-01-13 | CURRENT |
MR PHILIP JOHN DODGE | Dec 1966 | British | Director | 2021-01-13 | CURRENT |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Mr Robert Lee Harris | 2021-01-13 | 9/1980 | Abercynon Rct | Ownership of shares 25 to 50 percent |
Mr Philip John Dodge | 2021-01-13 | 12/1966 | Abercynon Rct | Ownership of shares 25 to 50 percent |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
ABSOLUTE BIOMEDICAL LTD | 2024-04-30 | 31-01-2024 | £39,900 equity |
Absolute Biomedical Ltd - Accounts to registrar (filleted) - small 23.1.2 | 2023-07-26 | 31-01-2023 | £8,825 equity |
Absolute Biomedical Ltd - Accounts to registrar (filleted) - small 18.2 | 2022-06-14 | 31-01-2022 | £-3,529 equity |